INMUNE BIO INC. Increase (Decrease) in Other Deferred Liability
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Other Deferred Liability of $300.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2020-08-05
- INMUNE BIO INC. increase (decrease) in other deferred liability for the quarter ending 2020-06-30 was $0.00.
- INMUNE BIO INC. increase (decrease) in other deferred liability for the quarter ending 2020-03-31 was $300.00K.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month |
|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $300.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $300.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |